Polygenic risk scores can improve prevention and early detection of cancer.
Research group in Oslo Cancer Cluster Incubator develops new cancer treatment
Three Nordic start-ups pitched at the International Cancer Cluster Showcase 2023. This year’s International Cancer Cluster Showcase (ICCS) featured 20 emerging oncology companies that presented their recent innovations, partnering and investment opportunities on 5 June 2023 in Boston, as a satellite event to BIO International Convention. The companies were selected by innovation hubs in the […]
Investors wanted to learn about Norwegian cancer companies.
NorTrials Medisinsk utstyr har inngått en samarbeidsavtale med HealthCatalyst AS.
Patient and industry perspectives are key as new board members join Oslo Cancer Cluster.
Could a screening programme reduce lung cancer mortality in Norway?
Antegenes supports the recent guidance from the AMCG.
How can the Nordics use health data to accelerate the development of cancer precision medicine?